22.418 articles found

Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates.

Quik M, Parameswaran N, McCallum SE, Bordia T, Bao S, McCormack A, Kim A, Tyndale RF, Langston JW, Di Monte DA.

J Neurochem · 2006-08-01

DOI: 10.1111/j.1471-4159.2006.04078.xPMID: 16882311

COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATION AND STROKE

HERGENROTHER Paul J., PUTT Karson S., LIU Xianjun.

· 2006-07-26

Compounds for the Treatment of Neurodegeneration and Stroke

HERGENROTHER PAUL J, PUTT KARSON S, LIU XIANJUN.

· 2006-07-26

Identification, diagnosis, and treatment of neuropathologies, neurotoxicities, tumors, and brain and spinal cord injuries using electrodes with microvoltammetry

BRODERICK PATRICIA A, PACIA STEVEN V.

· 2006-07-21

PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC AND AMYLOIDOGENIC DISEASE

SCHENK Dale B., MASLIAH Eliezer, BUTTINI Manuel J., CHILCOTE Tamie J., ROCKENSTEIN Edward, GAMES Dora Kate.

· 2006-07-19

PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC AND AMYLOIDOGENIC DISEASE

MASLIAH ELIEZER, SCHENK DALE B, GAMES DORA KATE, ROCKENSTEIN EDWARD, CHILCOTE TAMIE J, BUTTINI MANUEL J.

· 2006-07-19

Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of parkinson's disease, other movement disorders, and/or drug side effects

WYLER ALLEN, FOWLER BRAD.

· 2006-07-18

Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of parkinson's disease, other movement disorders, and/or drug side effects

WYLER ALLEN, FOWLER BRAD.

· 2006-07-18

New directions for neurodegenerative disease therapy: using chemical compounds to boost the formation of mutant protein inclusions.

Bodner RA, Housman DE, Kazantsev AG.

Cell Cycle · 2006-07-17

DOI: 10.4161/cc.5.14.2929PMID: 16861893

1-BENZYL-5-PIPERAZIN-1-YL-3,4-DIHYDRO-1H- QUINAZOLIN-2-ONE DERIVATIVES AND THE RESPECTIVE 1H-BENZO(1,2,6)THIADIAZINE-2,2-DIOXIDE AND 1,4-DIHYDRO-BENZO(D) (1,3)OXAZIN-2-ONE DERIVATIVES AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR(5-HT) FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM

SUI MENG, ZHAO SHU HAI.

· 2006-07-14

Network modulation in the treatment of Parkinson's disease.

Asanuma K, Tang C, Ma Y, Dhawan V, Mattis P, Edwards C, Kaplitt MG, Feigin A, Eidelberg D.

Brain · 2006-07-14

DOI: 10.1093/brain/awl162PMID: 16844713

THERAPEUTIC AGENTS

GIORDANETTO Fabrizio, INGHARDT Tord, NORDBERG Peter.

· 2006-07-13